Omega-3 Fatty Acids in Depression: A Review of Three Studies
- 1 June 2009
- journal article
- review article
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 15 (2), 128-133
- https://doi.org/10.1111/j.1755-5949.2008.00061.x
Abstract
We review three studies of omega‐3 fatty acids in the treatment of depression that were carried out by our research group at the Beer Sheva Mental Health Center. The first study examined eicosapentaenoic acid (EPA) versus placebo as an adjunct to antidepressant treatment in 20 unipolar patients with recurrent major depression. The second study used omega‐3 fatty acids in childhood major depression; 28 children aged 6–12 were randomized to omega‐3 fatty acids or placebo as pharmacologic monotherapy. The third study was an open‐label add‐on trial of EPA in bipolar depression. Twelve bipolar outpatients with depressive symptoms were treated with 1.5–2.0 g/day of EPA for up to 6 months. In the adult unipolar depression study, highly significant benefits were found by week 3 of EPA treatment compared with placebo. In the child study, an analysis of variance (ANOVA) showed highly significant effects of omega‐3 on each of the three rating scales. In the bipolar depression study, 8 of the 10 patients who completed at least 1 month of follow‐up achieved a 50% or greater reduction in Hamilton depression (Ham‐D) scores within 1 month. No significant side effects were reported in any of the studies. Omega‐3 fatty acids were shown to be more effective than placebo for depression in both adults and children in small controlled studies and in an open study of bipolar depression. (This review discusses three studies, all from our group, completed before the clinical trial registry was initiated.)Keywords
This publication has 30 references indexed in Scilit:
- A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorderEuropean Neuropsychopharmacology, 2008
- Plasma free polyunsaturated fatty acid levels are associated with symptom severity in acute maniaBipolar Disorders, 2007
- Omega-3 fatty acid monotherapy for pediatric bipolar disorder: A prospective open-label trialEuropean Neuropsychopharmacology, 2007
- Do essential fatty acids have a role in the treatment of depression?Journal of Affective Disorders, 2006
- Clinical trials of PUFAs in depression: State of the artThe World Journal of Biological Psychiatry, 2006
- Omega-3 Eicosapentaenoic Acid in Bipolar DepressionPublished by Physicians Postgraduate Press, Inc ,2005
- Omega-3 Fatty Acid Treatment of Women With Borderline Personality Disorder: A Double-Blind, Placebo-Controlled Pilot StudyAmerican Journal of Psychiatry, 2003
- Addition of Omega-3 Fatty Acid to Maintenance Medication Treatment for Recurrent Unipolar Depressive DisorderAmerican Journal of Psychiatry, 2002
- Phospholipid metabolism and depression: the possible roles of phospholipase A2 and coenzyme A-independent transacylaseHuman Psychopharmacology: Clinical and Experimental, 2001
- The effect of docosahexaenoic acid on aggression in young adults. A placebo-controlled double-blind study.JCI Insight, 1996